[CANCER PATIENTS FOLLOW-UP CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer]. / PRACENJE ONKOLOSKIH BOLESNIKA KLINICKE PREPORUKE HRVATSKOG DRUSTVA ZA INTERNISTICKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokracnog mjehura, rak prostate, rak testis.
Lijec Vjesn
; 138(7-8): 167-72, 2016.
Article
em Hr
| MEDLINE
| ID: mdl-30091881
ABSTRACT
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the followup of oncological patients after primary treatment, in patients with renal cell cancer, urinary bladder cancer, prostate cancer and testicular cancer.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Neoplasias Testiculares
/
Neoplasias da Bexiga Urinária
/
Assistência ao Convalescente
/
Oncologia
Tipo de estudo:
Diagnostic_studies
/
Guideline
/
Observational_studies
Limite:
Female
/
Humans
/
Male
País/Região como assunto:
Europa
Idioma:
Hr
Ano de publicação:
2016
Tipo de documento:
Article